Juvenile Undifferentiated Connective Tissue Disease
Undifferentiated Connective Tissue Disease (UCTD) features symptoms of multiple auto-immune diseases, but doesn't fall into a specific diagnosis. These symptoms limit a child's ability to thrive, but should be treated similarly to any other auto-immune disease with prompt and professional care.
Our pediatric rheumatology specialists provide highly specialized diagnosis and treatment for children and teens that have auto-immune diseases and disorders of the musculoskeletal system.
Treatments for Juvenile Undifferentiated Connective Tissue Disease
Symptoms of undifferentiated connective tissue disease (UCTD) present differently from person to person. Our pediatric rheumatology specialists will develop a personalized plan to try and manage your child's specific symptoms.
These new drugs are called “biologics” because they’re made from active biological material, rather than chemical compounds. Many are monoclonal antibodies, or drugs that behave like human antibodies trained to attack a specific threat to the immune system. Some of these medications are given through skin injections or intravenous infusion. Patients have access to the top-notch on-site infusion center.
Non-Biological Disease Modifying Ant-Rheumatic Drugs (DMARDs)
Different chemical treatments, such as low dose Methotrexate, may be needed to control a child’s JIA.
Non-Steroidal Anti-Inflammatory Drugs
Using prescription medicine can be an effective treatment for JIA. Our team continues to monitor children and perform routine follow-ups (often every 2-3 months).